Atlas Trials

Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion

Clinical trial NCT04388189 · WITHDRAWN

Trial details

NCT number
NCT04388189
Sponsor
Alto Neuroscience
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2020-10-15
Primary completion
2023-05-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.